News Daily News ‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database Michael O'Riordan August 21, 2024
News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Daily News Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE Yael L. Maxwell August 19, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Daily News Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes Michael O'Riordan August 19, 2024
News Daily News CMS Announces Negotiated Medicare Prices for First 10 Drugs Yael L. Maxwell August 16, 2024
News Daily News Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors Yael L. Maxwell August 15, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Daily News Scoring System Puts Focus on Medical Therapy Optimization in HFrEF L.A. McKeown August 13, 2024
News Daily News Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources Todd Neale August 12, 2024
News Daily News Acute HF Patients Live Longer When Seen by Specialists Michael O'Riordan August 09, 2024
News Daily News Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky Yael L. Maxwell August 08, 2024
News Daily News Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs Caitlin E. Cox August 08, 2024
News Daily News FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF L.A. McKeown August 05, 2024
News Daily News PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives Michael O'Riordan August 02, 2024
News Daily News SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results Yael L. Maxwell August 01, 2024